Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency
- PMID: 11306875
- DOI: 10.1159/000052474
Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency
Abstract
Objective: To assess the results of transurethral implantation of Macroplastique in women with stress incontinence secondary to urethral sphincter deficiency using subjective and objective outcome measures.
Methods: A total of 60 women with genuine stress incontinence secondary to intrinsic urethral sphincter deficiency were treated with transurethral implantation of Macroplastique. The patients had undergone a mean of 1.9 (range 0-7) previous episodes of continence surgery. Up to three treatment episodes were used, if necessary. The outcome was assessed by telephone interview (56 patients, mean follow-up period 19 months) and videocystometry (41 patients, mean follow-up period 16 months). Transurethral ultrasound scanning was performed in a further 9 patients.
Results: Symptomatically, 19.6% of the women interviewed by telephone considered themselves cured of their incontinence or were no longer using pads. A further 41.1% said their symptoms had significantly improved. Pad usage was reduced from a median of five to three pads per day (p < 0.001). Videocystometry in 41 women (mean follow-up period 16 months) was normal in 16 patients (39%) and showed genuine stress incontinence in 18 (43.9%) and detrusor instability in 12 patients (29.3%). Overall, 71.4% stated that they would undergo the procedure again under the same circumstances, and 80.4% would recommend this form of treatment to a friend with the same condition. Transurethral ultrasound scanning was performed in 9 patients (5 subjectively improved or cured, 1 patient with persistent symptoms but normal cystometry, and 3 patients with persistent genuine stress incontinence). Hyperechoic foci were seen surrounding the proximal urethra, consistent with implanted Macroplastique boluses. When completely encircling the urethra, the outcome was generally good. A total of 10 patients have undergone or are awaiting open surgery, and 3 are awaiting repeat implantation.
Conclusion: Sustained improvement or cure of genuine stress incontinence has been achieved using Macroplastique in a large proportion of women with intrinsic sphincter deficiency, often following previous unsuccessful continence surgery. Transurethral ultrasound may prove to be a clinically useful imaging technique for the assessment and subsequent management of treatment failure following Macroplastique implantation.
Similar articles
-
Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.Int Urogynecol J Pelvic Floor Dysfunct. 2005 Mar-Apr;16(2):147-50; discussion 150. doi: 10.1007/s00192-004-1216-y. Epub 2004 Sep 18. Int Urogynecol J Pelvic Floor Dysfunct. 2005. PMID: 15378234 Clinical Trial.
-
Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial.BJOG. 2005 Jun;112(6):797-801. doi: 10.1111/j.1471-0528.2005.00547.x. BJOG. 2005. PMID: 15924540 Clinical Trial.
-
Treatment of postoperative male urinary incontinence using transurethral macroplastique injections.J Endourol. 2003 Mar;17(2):113-5. doi: 10.1089/08927790360587450. J Endourol. 2003. PMID: 12689406
-
[Intrinsic sphincter deficiency and female urinary incontinence].Prog Urol. 2015 Jun;25(8):437-54. doi: 10.1016/j.purol.2015.03.006. Epub 2015 Apr 9. Prog Urol. 2015. PMID: 25864653 Review. French.
-
Is it possible to diagnose intrinsic sphincter deficiency in women?Curr Opin Urol. 2009 Jul;19(4):342-6. doi: 10.1097/MOU.0b013e32832ae1cb. Curr Opin Urol. 2009. PMID: 19444119 Review.
Cited by
-
Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report.Case Rep Womens Health. 2024 Sep 5;43:e00649. doi: 10.1016/j.crwh.2024.e00649. eCollection 2024 Oct. Case Rep Womens Health. 2024. PMID: 39314984 Free PMC article.
-
Treatment of stress urinary incontinence: recent developments in the role of urethral injection.Urol Res. 2003 Feb;30(6):356-62. doi: 10.1007/s00240-002-0290-1. Epub 2003 Jan 30. Urol Res. 2003. PMID: 12599014 Review.
-
Treatment options for intrinsic sphincter deficiency.Nat Rev Urol. 2012 Nov;9(11):638-51. doi: 10.1038/nrurol.2012.177. Epub 2012 Oct 2. Nat Rev Urol. 2012. PMID: 23027065 Review.
-
A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence.Int Urogynecol J. 2013 Jan;24(1):27-36. doi: 10.1007/s00192-012-1825-9. Epub 2012 Jun 15. Int Urogynecol J. 2013. PMID: 22699885 Free PMC article.
-
Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.Int Urogynecol J. 2013 Jul;24(7):1151-9. doi: 10.1007/s00192-012-1983-9. Epub 2012 Nov 15. Int Urogynecol J. 2013. PMID: 23229417
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical